The FDA reviewed results from more than 4,600 children in the 5-11 age range who were part of the Pfizer-BioNTech COVID-19 vaccine trial.
Except for pain at the injection site, most side effects were seen after the second dose of the vaccine.
By using this website, you accept the terms of our Visitor Agreement and Privacy Policy, and understand your options regarding Ad Choices.